MAGNAPERA, ALESSIA
 Distribuzione geografica
Continente #
NA - Nord America 116
AS - Asia 89
EU - Europa 41
SA - Sud America 17
AF - Africa 3
Totale 266
Nazione #
US - Stati Uniti d'America 108
SG - Singapore 42
CN - Cina 17
VN - Vietnam 14
BR - Brasile 11
RU - Federazione Russa 10
IT - Italia 8
HK - Hong Kong 5
JP - Giappone 5
CA - Canada 4
DE - Germania 4
GB - Regno Unito 4
MX - Messico 4
ES - Italia 3
FI - Finlandia 3
BD - Bangladesh 2
PL - Polonia 2
UA - Ucraina 2
UY - Uruguay 2
AR - Argentina 1
AT - Austria 1
CH - Svizzera 1
CI - Costa d'Avorio 1
EC - Ecuador 1
EG - Egitto 1
IL - Israele 1
IN - India 1
IQ - Iraq 1
LV - Lettonia 1
NG - Nigeria 1
NL - Olanda 1
PY - Paraguay 1
SA - Arabia Saudita 1
SE - Svezia 1
VE - Venezuela 1
Totale 266
Città #
San Jose 27
Singapore 24
Council Bluffs 11
Ashburn 10
Los Angeles 9
Ho Chi Minh City 7
Rome 5
Tokyo 5
Beijing 4
Hong Kong 4
Chicago 3
Creede 3
Helsinki 3
Montreal 3
Orem 3
São Paulo 3
Canoas 2
Dallas 2
Hanoi 2
London 2
Mexico City 2
Montevideo 2
New York 2
Poplar 2
Abidjan 1
Amsterdam 1
Annapolis 1
Atlanta 1
Barcelona 1
Baton Rouge 1
Belford Roxo 1
Bila Tserkva 1
Blumenau 1
Bologna 1
Buffalo 1
Caçapava 1
Centenario 1
Changzhi 1
Chennai 1
Denver 1
Dezhou 1
Frankfurt am Main 1
Guadalajara 1
Hurghada 1
Hải Dương 1
Itá 1
Jacksonville 1
Jeddah 1
Kyiv 1
Lages 1
Lekki 1
Los Alamitos 1
Miami 1
Milan 1
Moscow 1
Nam Định 1
Oklahoma City 1
Plano 1
Quito 1
Redford 1
Riga 1
Riverside 1
Shanghai 1
Sorocaba 1
Stockholm 1
São Carlos 1
Tampa 1
Thuận An 1
Tiền Hải 1
Tlaxcala City 1
Toronto 1
Warsaw 1
Zurich 1
Totale 189
Nome #
A peculiar HBsAg isoforms composition characterizes chronic HDV coinfection respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity. 67
Insights into the Currently Available Drugs and Investigational Compounds Against RSV with a Focus on Their Drug-Resistance Profiles 66
Chronic HDV coinfection is characterized by a peculiar HBsAg isoforms composition respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity. 54
HBV integration can sustain intrahepatic HDV activity and can modulate HBV pathogenetic potential. 17
HDV sub-genotype 1 is characterized by increased genetic variability, which can promote the emergence of divergent genetic pathways that modulate HDV replicative potential and cytolytic activity. 17
A high degree of genetic variability characterises HDV sub-genotypes 1 and can drive the selection of divergent genetic pathways modulating HDV replicative potential and cytolytic activity. 15
Kinetics of occult hepatitis B infection in people with HIV switching from HBV-active ART to long-acting cabotegravir/rilpivirine 15
HDV sub-genotype 1 is characterized by increased genetic variability, which can promote the emergence of divergent genetic pathways that modulate HDV replicative potential and cytolytic activity. 15
An increased genetic variability characterises HDV sub-genotypes 1 and can drive the selection of divergent genetic pathways modulating HDV replicative potential and cytolytic activity 15
Chronic HDV coinfection is characterized by a more elevated production of all three HBsAg isoforms compared to HBV mono-infection, that parallels HDV replicative and cytolytic activity. 15
Totale 296
Categoria #
all - tutte 608
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 608


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2025/2026296 23 6 24 25 27 11 16 23 69 72 0 0
Totale 296